Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$37.22 - $100.5 $13.3 Million - $35.9 Million
356,888 New
356,888 $13.6 Million
Q2 2022

Aug 15, 2022

SELL
$48.99 - $57.46 $14.7 Million - $17.2 Million
-300,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$48.48 - $53.65 $10.3 Million - $11.4 Million
211,751 Added 239.95%
300,000 $15.4 Million
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $4.15 Million - $4.62 Million
88,249 New
88,249 $4.42 Million
Q1 2021

May 14, 2021

SELL
$45.46 - $50.51 $10 Million - $11.1 Million
-220,201 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$45.3 - $51.62 $9.98 Million - $11.4 Million
220,201 New
220,201 $10.7 Million
Q1 2020

May 15, 2020

SELL
$38.02 - $51.66 $6.5 Million - $8.83 Million
-170,977 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$44.25 - $50.86 $7.57 Million - $8.7 Million
170,977 New
170,977 $8.58 Million
Q2 2019

Aug 14, 2019

SELL
$40.43 - $44.3 $6.34 Million - $6.95 Million
-156,854 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$40.83 - $45.43 $4.55 Million - $5.07 Million
-111,534 Reduced 41.56%
156,854 $6.95 Million
Q4 2018

Feb 14, 2019

BUY
$41.48 - $45.59 $82,960 - $91,180
2,000 Added 0.75%
268,388 $11.7 Million
Q3 2018

Nov 14, 2018

BUY
$40.0 - $44.84 $4.65 Million - $5.22 Million
116,330 Added 77.52%
266,388 $11.9 Million
Q2 2018

Aug 14, 2018

SELL
$37.63 - $41.22 $9.73 Million - $10.7 Million
-258,563 Reduced 63.28%
150,058 $6 Million
Q1 2018

May 15, 2018

BUY
$38.98 - $45.76 $15.9 Million - $18.7 Million
408,621 New
408,621 $16.4 Million
Q4 2017

Feb 14, 2018

SELL
$42.86 - $50.61 $1.93 Million - $2.28 Million
-45,099 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$47.04 - $50.34 $2.12 Million - $2.27 Million
45,099
45,099 $2.25 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $120B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.